Revlimid and myelodysplastic syndrome Patient Reports February 11, 2012



Revlimid Side Effects Report #5194106-X
Revlimid side effect was reported by a Physician from UNITED STATES on Dec 18, 2006. Male patient, 84 years of age, was diagnosed with refractory anaemia and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome, platelet count decreased, refractory anaemia. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with XALATAN, MEGACE, PROTONIX, LEVOXYL, DIOVAN, CARDURA, DETROL LA. Patient died on 11/01/2006.

Revlimid Side Effects Report #5194100-9
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 20, 2006. Male patient, 72 years of age, was diagnosed with neoplasm and was treated with Revlimid. After drug was administered, patient experienced the following side effects: gastric cancer, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 12/09/2006.

Revlimid Side Effects Report #5251977-6
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 13, 2007. Male patient, 62 years of age, was diagnosed with neoplasm and was treated with Revlimid. After drug was administered, patient experienced the following side effects: coronary artery disease What is  coronary artery disease, disease progression, myelodysplastic syndrome, myeloproliferative disorder, myocardial infarction, renal failure. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/22/2007.

Revlimid Side Effects Report #5705177-3
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 03, 2008. Male patient, 70 years of age, was diagnosed with myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: coronary artery stenosis, disease progression, hypertension, myelodysplastic syndrome, myelofibrosis, pancytopenia, pneumonia What is  pneumonia, pseudomonal sepsis. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 12/14/2007.


Revlimid Side Effects Report #5706381-0
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 03, 2008. Male patient, 70 years of age, was diagnosed with myelofibrosis and was treated with Revlimid. After drug was administered, patient experienced the following side effects: 5q-syndrome, coronary artery stenosis, disease progression, hypertension, myelodysplastic syndrome, myelofibrosis, pneumonia What is  pneumonia, pseudomonal sepsis. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 12/14/2007.

Revlimid Side Effects Report #5145553-3
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 25, 2006. Male patient, 96 years of age, was diagnosed with myelodysplastic syndrome, multiple myeloma What is  multiple myeloma and was treated with Revlimid. After drug was administered, patient experienced the following side effects: blood erythropoietin increased, disease progression, myelodysplastic syndrome, prothrombin time prolonged, pulmonary embolism What is  pulmonary embolism, serum ferritin increased. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with THALOMID, COUMADIN. Patient died on 05/26/2006.

Revlimid Side Effects Report #5140201-0
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 19, 2006. Male patient, 95 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 01/01/2006.

Revlimid Side Effects Report #5164128-3
Revlimid side effect was reported by a Physician from UNITED STATES on Nov 15, 2006. Male patient, 95 years of age, weighting 150.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, dysphonia, dyspnoea, fatigue, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with VITAMIN, PROTONIX, DIGOXIN, ASPIRIN, FOLIC ACID, POTASSIUM, LASIX. Patient was hospitalized. Patient died on 10/11/2006.

Revlimid Side Effects Report #5402164-X
Revlimid side effect was reported by a Physician from UNITED STATES on July 23, 2007. Male patient, 93 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome, neoplasm progression, pancytopenia, sepsis What is  sepsis. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 11/18/2006.


Revlimid Side Effects Report #5472190-3
Revlimid side effect was reported by a Physician from UNITED STATES on Sept 20, 2007. Male patient, 91 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/01/2007.

Revlimid Side Effects Report #5463805-4
Revlimid side effect was reported by a Physician from UNITED STATES on Sept 11, 2007. Male patient, 90 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome, renal failure chronic. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with SYNTHROID, ARANESP, COREG, LASIX. Patient was hospitalized. Patient died on 07/13/2007.

Revlimid Side Effects Report #5489240-0
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 10, 2007. Male patient, 90 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, haemoglobin decreased, myelodysplastic syndrome, platelet count decreased. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with SYNTHROID, ARANESP, COREG, LASIX. Patient was hospitalized. Patient died on 07/13/2007.

Revlimid Side Effects Report #5502784-8
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 23, 2007. Male patient, 90 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, haemoglobin decreased, myelodysplastic syndrome, platelet count decreased, renal failure chronic. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with SYNTHROID, ARANESP, COREG, LASIX. Patient was hospitalized. Patient died on 07/13/2007.

Revlimid Side Effects Report #5525045-X
Revlimid side effect was reported by a Physician from UNITED STATES on Nov 13, 2007. Female patient, 90 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 01/01/2007.


Revlimid Side Effects Report #5671703-6
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 10, 2008. Female patient, 90 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 12/30/2007.

Revlimid Side Effects Report #5566878-3
Revlimid side effect was reported by a Physician from UNITED STATES on Dec 11, 2007. Male patient, 89 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL, 5-10 MG, ORAL. Patient was hospitalized. Patient died on 09/01/2007.

Revlimid Side Effects Report #5378035-4
Revlimid side effect was reported by a Physician from UNITED STATES on June 25, 2007. Male patient, 88 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome, myocardial infarction. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 03/19/2007.

Revlimid Side Effects Report #5391048-1
Revlimid side effect was reported by a Physician from UNITED STATES on July 11, 2007. Male patient, 88 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 2 IN 1 D, ORAL. Patient died on 05/02/2007.

Revlimid Side Effects Report #5821534-9
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2008. Female patient, 88 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 06/01/2008.


Revlimid Side Effects Report #5242064-1
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 01, 2007. Female patient, 87 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 09/21/2006.

Revlimid Side Effects Report #5141693-3
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 16, 2006. Male patient, 87 years of age, was diagnosed with myelodysplastic syndrome, refractory anaemia with an excess of blasts and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with MONOPRIL, PLAVIX, SYNTHROID, LANOXIN. Patient died on 07/04/2006.

Revlimid Side Effects Report #5165850-5
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 21, 2006. Female patient, 86 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 10/21/2006.

Revlimid Side Effects Report #5388768-1
Revlimid side effect was reported by a Physician from UNITED STATES on July 06, 2007. Female patient, 86 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, failure to thrive, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 03/23/2006.

Revlimid Side Effects Report #5748572-9
Revlimid side effect was reported by a Physician from UNITED STATES on May 14, 2008. Female patient, 86 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, leukaemia, myelodysplastic syndrome, pancytopenia. Revlimid dosage: 5 MG, EVERY OTHER DAY, ORAL. Patient died.


Revlimid Side Effects Report #5218799-3
Revlimid side effect was reported by a Physician from UNITED STATES on Jan 17, 2007. Female patient, 85 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, leukaemia, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 12/18/2006.

Revlimid Side Effects Report #5481954-1
Revlimid side effect was reported by a Physician from UNITED STATES on Sept 26, 2007. Male patient, 85 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant transformation, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 07/18/2006.

Revlimid Side Effects Report #5565785-X
Revlimid side effect was reported by a Physician from UNITED STATES on Dec 07, 2007. Male patient, 85 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome, respiratory arrest. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 11/07/2007.

Revlimid Side Effects Report #5610342-X
Revlimid side effect was reported by a Physician from UNITED STATES on Jan 23, 2008. Male patient, 85 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome, respiratory arrest. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 11/07/2007.

Revlimid Side Effects Report #5625328-9
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 04, 2008. Male patient, 85 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome, respiratory arrest. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 11/07/2007.


Revlimid Side Effects Report #5229312-9
Revlimid side effect was reported by a Physician from UNITED STATES on Jan 26, 2007. Male patient, 84 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: decreased appetite, diarrhoea, disease progression, myelodysplastic syndrome, nausea What is  nausea, pneumonia aspiration, stomach discomfort. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with COUMADIN, ALLOPURINOL, COREG, VITAMIN B12, DIGOXIN, PROCRIT, LASIX. Patient was hospitalized. Patient died on 11/28/2006.

Revlimid Side Effects Report #5232036-5
Revlimid side effect was reported by a Physician from UNITED STATES on Jan 29, 2007. Male patient, 84 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died.

Revlimid Side Effects Report #5255175-1
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 20, 2007. Male patient, 84 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: chest pain What is  chest pain, disease progression, dyspnoea, myelodysplastic syndrome, respiratory arrest. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 01/29/2007.

Revlimid Side Effects Report #5277952-3
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 13, 2007. Female patient, 84 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: abdominal pain lower, deep vein thrombosis What is  deep vein thrombosis, disease progression, myelodysplastic syndrome, pain in extremity, pleuritic pain, pyrexia, splenic infarction. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with AZACTIDINE. Patient was hospitalized. Patient died on 12/09/2006.

Revlimid Side Effects Report #5374054-2
Revlimid side effect was reported by a Physician from UNITED STATES on June 19, 2007. Male patient, 84 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 05/31/2007.


Revlimid Side Effects Report #5701638-1
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 02, 2008. Female patient, 84 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, DAILY X21 DAYS, ORAL. Patient died.

Revlimid Side Effects Report #5840394-3
Revlimid side effect was reported by a Physician from UNITED STATES on Aug 01, 2008. Female patient, 84 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL; 5-10 MG, DAILY, ORAL. Patient died.

Revlimid Side Effects Report #5242578-4
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 06, 2007. Female patient, 83 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, gastrointestinal haemorrhage, myelodysplastic syndrome, renal failure. Revlimid dosage: 10 MG, 2 IN 1 D, ORAL. Patient was hospitalized. Patient died on 06/01/2006.

Revlimid Side Effects Report #5284229-9
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 20, 2007. Male patient, 83 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 03/18/2007.

Revlimid Side Effects Report #5348951-8
Revlimid side effect was reported by a Physician from UNITED STATES on May 29, 2007. Female patient, 83 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, gastrointestinal haemorrhage, myelodysplastic syndrome, pancytopenia, renal failure, vomiting. Revlimid dosage: 10 MG, 2 IN 1 D, ORAL. During the same period patient was treated with ARANESP, SYNTHROID, TOPROL, FOLIC ACID, VITAMIN B, NEUMEGA. Patient was hospitalized. Patient died on 06/01/2006.


Revlimid Side Effects Report #5063643-0
Revlimid side effect was reported by a Physician from UNITED STATES on July 05, 2006. Male patient, 83 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, anaemia, disease progression, disseminated intravascular coagulation, myelodysplastic syndrome, pancytopenia, pneumonia What is  pneumonia, renal failure, sepsis What is  sepsis. Revlimid dosage: unknown. Patient died on 06/25/2006.

Revlimid Side Effects Report #5472253-2
Revlimid side effect was reported by a Physician from UNITED STATES on Sept 21, 2007. Male patient, 83 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 02/24/2007.

Revlimid Side Effects Report #5657999-5
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 29, 2008. Male patient, 83 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 12/05/2007.

Revlimid Side Effects Report #5683220-8
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 19, 2008. Male patient, 83 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, malignant neoplasm progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 11/18/1923.

Revlimid Side Effects Report #5708891-9
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 08, 2008. Male patient, 83 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 01/18/2007.

Revlimid Side Effects Report #5337608-5
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on May 17, 2007. Male patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, fatigue, joint swelling, myelodysplastic syndrome, somnolence. Revlimid dosage: 10 MG, QD X28 DAYS, ORAL. During the same period patient was treated with PRILOSEC, CENTRUM SILVER, EXJADE. Patient died on 03/12/2007.

Revlimid Side Effects Report #5453498-4
Revlimid side effect was reported by a Physician from UNITED STATES on Sept 06, 2007. Male patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, dyspnoea, myelodysplastic syndrome, rash What is  rash, swelling face. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 06/22/2007.

Revlimid Side Effects Report #5467642-6
Revlimid side effect was reported by a Physician from UNITED STATES on Sept 18, 2007. Male patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, fatigue, joint swelling, myelodysplastic syndrome, somnolence. Revlimid dosage: 10 MG, QD X 28 DAYS, ORAL. During the same period patient was treated with PRILOSEC, CENTRUM SILVER, EXJADE. Patient died on 03/12/2007.

Revlimid Side Effects Report #5483617-5
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 02, 2007. Male patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: cardiac failure congestive, disease progression, myelodysplastic syndrome, rash What is  rash, swelling face. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 03/22/2007.

Revlimid Side Effects Report #5538303-X
Revlimid side effect was reported by a Physician from UNITED STATES on Nov 29, 2007. Female patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, QD, ORAL. Patient died on 05/31/2007.


Revlimid Side Effects Report #5639400-0
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 15, 2008. Female patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 01/10/2008.

Revlimid Side Effects Report #5643792-6
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 18, 2008. Male patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 01/08/2008.

Revlimid Side Effects Report #5712518-X
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 10, 2008. Male patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: anaemia, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D ORAL. Patient died on 03/09/2008.

Revlimid Side Effects Report #5713768-9
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 14, 2008. Male patient, 82 years of age, was diagnosed with myelodysplastic syndrome, refractory anaemia with an excess of blasts and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 01/26/2008.

Revlimid Side Effects Report #5786846-6
Revlimid side effect was reported by a Physician from UNITED STATES on June 16, 2008. Female patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, QD; ORAL. Patient died on 12/22/2007.

Revlimid Side Effects Report #5799183-0
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2008. Male patient, 82 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, QD X 21 DAYS Q 28 DAYS, ORAL. Patient died on 03/10/2008.

Revlimid Side Effects Report #5327302-9
Revlimid side effect was reported by a Physician from UNITED STATES on May 07, 2007. Female patient, 81 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: blood culture positive, disease progression, hypotension, klebsiella infection, myelodysplastic syndrome, pancytopenia, sepsis What is  sepsis. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 10/29/2006.

Revlimid Side Effects Report #5166101-8
Revlimid side effect was reported by a Physician from UNITED STATES on Nov 22, 2006. Female patient, 81 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, agranulocytosis, catheter related infection, malignant neoplasm progression, myelodysplastic syndrome, refusal of treatment by patient. Revlimid dosage: unknown. During the same period patient was treated with PEPCID, DIGOXIN, LORTAB, RESTORIL. Patient was hospitalized. Patient died on 08/01/2006.

Revlimid Side Effects Report #5193434-1
Revlimid side effect was reported by a Physician from UNITED STATES on Dec 15, 2006. Male patient, 81 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died.

Revlimid Side Effects Report #5099468-X
Revlimid side effect was reported by a Physician from UNITED STATES on Aug 29, 2006. Female patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 05/14/2006.


Revlimid Side Effects Report #5397867-X
Revlimid side effect was reported by a Physician from UNITED STATES on July 17, 2007. Female patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: arthralgia, disease progression, myelodysplastic syndrome, poor peripheral circulation, urinary retention. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with PROCRIT, EXJADE, PREDNISONE, CRESTOR, AZACITIDINE. Patient died on 01/01/2007.

Revlimid Side Effects Report #5415228-1
Revlimid side effect was reported by a Physician from UNITED STATES on Aug 07, 2007. Male patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 11/23/2006.

Revlimid Side Effects Report #5483618-7
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 02, 2007. Female patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, disease progression, febrile neutropenia, myelodysplastic syndrome. Revlimid dosage: 5 MG, QOD X 21 DAYS, 1 WEEK OFF, ORAL, 5 MG, QD X 21 DAYS, ORAM. Patient died on 06/19/2007.

Revlimid Side Effects Report #5657997-1
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 29, 2008. Male patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 06/26/2007.

Revlimid Side Effects Report #5775421-5
Revlimid side effect was reported by a Physician from UNITED STATES on June 05, 2008. Male patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with ASPIRIN, FLONASE NASAL, LISINOPRIL, NEXIUM, COLLACE, HUMULIN R, HUMULIN R, LOPRESSOR. Patient died on 05/19/2008.

Revlimid Side Effects Report #5797641-6
Revlimid side effect was reported by a Physician from UNITED STATES on June 24, 2008. Male patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, malignant neoplasm progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 06/26/2007.

Revlimid Side Effects Report #5836151-4
Revlimid side effect was reported by a Physician from UNITED STATES on July 29, 2008. Male patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with ASPIRIN, FLONASE NASAL, FLOMAX, COLACE, HUMULIN R, LOPRESSOR, COMPAZINE, INOSITOL. Patient died on 05/19/2008.

Revlimid Side Effects Report #4930250-7
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 22, 2006. Female patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, leukaemia, myelodysplastic syndrome. Revlimid dosage: 10 MG, DAILY, ORAL. Patient was hospitalized. Patient died on 02/17/2006.

Revlimid Side Effects Report #4952758-0
Revlimid side effect was reported by a Pharmacist from UNITED STATES on Mar 14, 2006. Male patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, DAILY, ORAL; 10 MG, DAILY, ORAL. During the same period patient was treated with ARTHROTEC, DYAZIDE, LIPITOR, NEXIUM, AMICAR, AMBIEN. Patient was hospitalized. Patient died on 03/01/2006.

Revlimid Side Effects Report #4976947-4
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 03, 2006. Male patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, DAILY, ORAL. Patient died on 03/25/2006.


Revlimid Side Effects Report #5032807-4
Revlimid side effect was reported by a Physician from UNITED STATES on June 12, 2006. Male patient, 80 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, DAILY, ORAL. Patient died on 05/20/2006.

Revlimid Side Effects Report #5237056-2
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 01, 2007. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome, thrombocytopenia, white blood cell count decreased. Revlimid dosage: unknown. Patient died on 11/17/2006.

Revlimid Side Effects Report #5274750-1
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 12, 2007. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 01/09/2007.

Revlimid Side Effects Report #5325864-9
Revlimid side effect was reported by a Physician from UNITED STATES on May 03, 2007. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 04/16/2007.

Revlimid Side Effects Report #5331610-5
Revlimid side effect was reported by a Physician from UNITED STATES on May 07, 2007. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, asthenia, disease progression, malaise, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 04/16/2007.

Revlimid Side Effects Report #5089023-X
Revlimid side effect was reported by a Physician from UNITED STATES on Aug 14, 2006. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. During the same period patient was treated with PYRIDOXINE, FOLATE, PROCRIT. Patient died on 06/11/2006.

Revlimid Side Effects Report #5194120-4
Revlimid side effect was reported by a Physician from UNITED STATES on Dec 12, 2006. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: malignant neoplasm progression, myelodysplastic syndrome, thrombocytopenia, white blood cell count decreased. Revlimid dosage: unknown. Patient died on 11/17/2006.

Revlimid Side Effects Report #5408476-8
Revlimid side effect was reported by a Physician from UNITED STATES on July 31, 2007. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, fatigue, myelodysplastic syndrome, rash What is  rash. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 05/16/2007.

Revlimid Side Effects Report #5445654-6
Revlimid side effect was reported by a Physician from UNITED STATES on Aug 28, 2007. Male patient, 79 years of age, weighting 245.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 2.1429 MG, 3 IN 1 WK, ORAL. Patient died on 06/30/2007.

Revlimid Side Effects Report #5483619-9
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 01, 2007. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood count abnormal, condition aggravated, disease progression, myelodysplastic syndrome, refractory anaemia. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL, 10 MG, 1 IN 1 D, ORAL. Patient was hospitalized. Patient died on 04/20/2007.


Revlimid Side Effects Report #5587657-7
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 31, 2007. Male patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, QD, ORAL. Patient died on 12/29/2007.

Revlimid Side Effects Report #5792710-9
Revlimid side effect was reported by a Physician from UNITED STATES on June 17, 2008. Female patient, 79 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, haemorrhage, myelodysplastic syndrome, nervous system disorder. Revlimid dosage: 5 MG, DAILY FOR 21 DAYS, ORAL. Patient died on 02/01/2008.

Revlimid Side Effects Report #5316316-0
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 23, 2007. Female patient, 78 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 04/03/2007.

Revlimid Side Effects Report #5198373-8
Revlimid side effect was reported by a Health Professional from UNITED STATES on Dec 26, 2006. Male patient, 78 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 12/26/2006.

Revlimid Side Effects Report #5415204-9
Revlimid side effect was reported by a Physician from UNITED STATES on Aug 07, 2007. Female patient, 78 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 05/12/2007.

Revlimid Side Effects Report #5470255-3
Revlimid side effect was reported by a Physician from UNITED STATES on Sept 18, 2007. Female patient, 78 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, QD, ORAL. Patient died on 06/26/2007.

Revlimid Side Effects Report #5504987-5
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 26, 2007. Male patient, 78 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D; ORAL. Patient died on 09/07/2007.

Revlimid Side Effects Report #5624504-9
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 04, 2008. Female patient, 78 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, diarrhoea, disease progression, myelodysplastic syndrome, purpura, thrombocytopenia. Revlimid dosage: 2.5 MG, 1 IN 2 D, ORAL ; 5 MG, 1 IN 1 D ORAL. Patient died.

Revlimid Side Effects Report #5668530-2
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 07, 2008. Female patient, 78 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, diarrhoea, disease progression, myelodysplastic syndrome, purpura. Revlimid dosage: 2.5 MG, 1 IN 2 D, ORAL, 5 MG, 1 IN 1 D, ORAL, 5 MG, 1 IN 1 D, ORAL. Patient died.

Revlimid Side Effects Report #5726064-0
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 19, 2008. Male patient, 78 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, disease progression, leukostasis, myelodysplastic syndrome. Revlimid dosage: 5 MG, QD X 28D, ORAL. Patient was hospitalized. Patient died on 04/03/2008.

Revlimid Side Effects Report #5761959-3
Revlimid side effect was reported by a Physician from UNITED STATES on May 27, 2008. Male patient, 78 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, disease progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, QD X 28D, ORAL. Patient was hospitalized. Patient died on 04/03/2008.

Revlimid Side Effects Report #5774826-6
Revlimid side effect was reported by a Physician from UNITED STATES on June 05, 2008. Female patient, 78 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, diarrhoea, disease progression, myelodysplastic syndrome, purpura, thrombocytopenia. Revlimid dosage: 2.5 MG, 1 IN 2 D, ORAL, 5 MG, 1 IN 1 D, ORAL, 10 MG, 1 IN 1 D, ORAL. Patient died on 01/25/2008.

Revlimid Side Effects Report #5237120-8
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 01, 2007. Male patient, 77 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, disease progression, myelodysplastic syndrome, pyrexia, rash What is  rash, swelling face. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. During the same period patient was treated with COUMADIN, GABAPENTIN, LASIX. Patient was hospitalized. Patient died.

Revlimid Side Effects Report #5320161-X
Revlimid side effect was reported by a Physician from UNITED STATES on Apr 27, 2007. Female patient, 77 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: cachexia, disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 2 IN 1 D, ORAL. Patient died on 03/24/2007.

Revlimid Side Effects Report #5509324-8
Revlimid side effect was reported by a Physician from UNITED STATES on Oct 30, 2007. Male patient, 77 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: asthenia, disease progression, epistaxis, myelodysplastic syndrome, thrombocytopenia. Revlimid dosage: 10 MG, DAILY, ORAL, 5 MG, DAILY, ORAL. Patient was hospitalized. Patient died on 06/28/2007.

Revlimid Side Effects Report #5606566-8
Revlimid side effect was reported by a Physician from UNITED STATES on Jan 21, 2008. Male patient, 77 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, 1 IN 1 D, ORAL. Patient died on 11/13/2007.

Revlimid Side Effects Report #5619680-8
Revlimid side effect was reported by a Physician from UNITED STATES on Jan 31, 2008. Male patient, 77 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute leukaemia, disease progression, myelodysplastic syndrome. Revlimid dosage: 10 MG, QD X 21 DAYS PER MONTH, ORAL; 5MG, 1 IN 1 D, ORAL; 2.5 MG, 1 IN 2 D, ORAL. Patient died on 12/30/2007.

Revlimid Side Effects Report #5637812-2
Revlimid side effect was reported by a Physician from UNITED STATES on Feb 14, 2008. Male patient, 77 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: blood count abnormal, disease progression, infection What is  infection, myelodysplastic syndrome, rash pruritic, sepsis What is  sepsis. Revlimid dosage: 5 MG, ORAL. Patient died on 01/25/2008.

Revlimid Side Effects Report #5680902-9
Revlimid side effect was reported by a Physician from UNITED STATES on Mar 18, 2008. Female patient, 77 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression, myelodysplastic syndrome. Revlimid dosage: 10-5 MG, DAILY, ORAL, 10 MG, DAILY; ORAL. Patient died on 01/31/2008.

Revlimid Side Effects Report #5815638-4
Revlimid side effect was reported by a Physician from UNITED STATES on July 08, 2008. Male patient, 77 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: cardiac arrest What is  cardiac arrest, malignant neoplasm progression, myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 01/01/2008.

Revlimid Side Effects Report #5831467-X
Revlimid side effect was reported by a Consumer or non-health professional from UNITED STATES on July 22, 2008. Female patient, 77 years of age, was diagnosed with myelodysplastic syndrome and was treated with Revlimid. After drug was administered, patient experienced the following side effects: myelodysplastic syndrome. Revlimid dosage: 5 MG, 1 IN 1 D, ORAL. Patient died on 07/15/2008.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Revlimid